CTOs on the Move

Tower Group Holding

www.towergroup.com

 
TowerGroup is the leading research and advisory services firm focused exclusively on the global financial services industry.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Long Beach Tennis Ctr

Long Beach Tennis Ctr is a Long Beach, NY-based company in the Business Services sector.

Cobalt Biofuels

Commercialization of biobutanol from non-food biomass as a replacement for petroleum based gasoline and chemicals.

InterCloud

InterCloud is a leading Software-Defined Cloud Interconnect (SDCI) provider that transforms global connectivity, reduces network complexity and accelerates growth and innovation for global business – securely, quickly and easily. Its end-to-end global connectivity platform eliminates the complexity in deploying the cloud, giving businesses full control over the security, sovereignty and performance of their critical data traffic with complete peace of mind. The companys platform is underpinned by its team of cloud experts who guide customers to implement effective strategies to leverage the power of the cloud across their organisation – giving customers the ultimate peace of mind that their business will be fit for future.

CNEX Labs

CNEX is a privately held company founded in 2013 and funded by venture capital and strategic investments from Fortune 500 companies in storage and networking.

Onward

ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries. ONWARD`s work builds on more than a decade of basic science and preclinical research conducted at the world`s leading neuroscience laboratories. ONWARD`s ARC Therapy, which can be delivered by implantable (ARC-IM) or external (ARC-EX) systems, is designed to deliver targeted, programmed spinal cord stimulation to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life. ONWARD has received five Breakthrough Device Designations from the US FDA encompassing both ARC-IM and ARC-EX. ARC-EX is an external, non-invasive platform consisting of a wearable stimulator and wireless programmer. Positive top-line data were reported in 2022 from the company`s first pivotal study, called Up-LIFT, evaluating the ability of transcutaneous ARC Therapy to improve upper extremity strength and function. The company is now preparing marketing approval submissions for the US and Europe. ARC-IM consists of an implantable pulse generator and lead that is placed near the spinal cord. The company completed its first-in-human use of the ARC-IM neurostimulator in 2022. ONWARD is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Center in Lausanne, Switzerland, and has a growing US presence in Boston, Massachusetts. The company has an academic partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Technology (EPFL) and Lausanne University Hospital (CHUV).